Animal Drugs-Global Market Status and Trend Report 2013-2023
Report Summary
Animal Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Animal Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Animal Drugs worldwide, with company and product introduction, position in the Animal Drugs market
Market status and development trend of Animal Drugs by types and applications
Cost and profit status of Animal Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Animal Drugs market as:
Global Animal Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Animal Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
Global Animal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
Global Animal Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Animal Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Animal Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Animal Drugs worldwide, with company and product introduction, position in the Animal Drugs market
Market status and development trend of Animal Drugs by types and applications
Cost and profit status of Animal Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Animal Drugs market as:
Global Animal Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Animal Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
Global Animal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
Global Animal Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Animal Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL DRUGS
1.1 Definition of Animal Drugs in This Report
1.2 Commercial Types of Animal Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Animal Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Animal Drugs
1.5 Market Status and Trend of Animal Drugs 2013-2023
1.5.1 Global Animal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Animal Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Animal Drugs 2013-2017
2.2 Sales Market of Animal Drugs by Regions
2.2.1 Sales Volume of Animal Drugs by Regions
2.2.2 Sales Value of Animal Drugs by Regions
2.3 Production Market of Animal Drugs by Regions
2.4 Global Market Forecast of Animal Drugs 2018-2023
2.4.1 Global Market Forecast of Animal Drugs 2018-2023
2.4.2 Market Forecast of Animal Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Animal Drugs by Types
3.2 Sales Value of Animal Drugs by Types
3.3 Market Forecast of Animal Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Animal Drugs by Downstream Industry
4.2 Global Market Forecast of Animal Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Animal Drugs Market Status by Countries
5.1.1 North America Animal Drugs Sales by Countries (2013-2017)
5.1.2 North America Animal Drugs Revenue by Countries (2013-2017)
5.1.3 United States Animal Drugs Market Status (2013-2017)
5.1.4 Canada Animal Drugs Market Status (2013-2017)
5.1.5 Mexico Animal Drugs Market Status (2013-2017)
5.2 North America Animal Drugs Market Status by Manufacturers
5.3 North America Animal Drugs Market Status by Type (2013-2017)
5.3.1 North America Animal Drugs Sales by Type (2013-2017)
5.3.2 North America Animal Drugs Revenue by Type (2013-2017)
5.4 North America Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Animal Drugs Market Status by Countries
6.1.1 Europe Animal Drugs Sales by Countries (2013-2017)
6.1.2 Europe Animal Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Animal Drugs Market Status (2013-2017)
6.1.4 UK Animal Drugs Market Status (2013-2017)
6.1.5 France Animal Drugs Market Status (2013-2017)
6.1.6 Italy Animal Drugs Market Status (2013-2017)
6.1.7 Russia Animal Drugs Market Status (2013-2017)
6.1.8 Spain Animal Drugs Market Status (2013-2017)
6.1.9 Benelux Animal Drugs Market Status (2013-2017)
6.2 Europe Animal Drugs Market Status by Manufacturers
6.3 Europe Animal Drugs Market Status by Type (2013-2017)
6.3.1 Europe Animal Drugs Sales by Type (2013-2017)
6.3.2 Europe Animal Drugs Revenue by Type (2013-2017)
6.4 Europe Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Animal Drugs Market Status by Countries
7.1.1 Asia Pacific Animal Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Animal Drugs Revenue by Countries (2013-2017)
7.1.3 China Animal Drugs Market Status (2013-2017)
7.1.4 Japan Animal Drugs Market Status (2013-2017)
7.1.5 India Animal Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Animal Drugs Market Status (2013-2017)
7.1.7 Australia Animal Drugs Market Status (2013-2017)
7.2 Asia Pacific Animal Drugs Market Status by Manufacturers
7.3 Asia Pacific Animal Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Animal Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Animal Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Animal Drugs Market Status by Countries
8.1.1 Latin America Animal Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Animal Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Animal Drugs Market Status (2013-2017)
8.1.4 Argentina Animal Drugs Market Status (2013-2017)
8.1.5 Colombia Animal Drugs Market Status (2013-2017)
8.2 Latin America Animal Drugs Market Status by Manufacturers
8.3 Latin America Animal Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Animal Drugs Sales by Type (2013-2017)
8.3.2 Latin America Animal Drugs Revenue by Type (2013-2017)
8.4 Latin America Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Animal Drugs Market Status by Countries
9.1.1 Middle East and Africa Animal Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Animal Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Animal Drugs Market Status (2013-2017)
9.1.4 Africa Animal Drugs Market Status (2013-2017)
9.2 Middle East and Africa Animal Drugs Market Status by Manufacturers
9.3 Middle East and Africa Animal Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Animal Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Animal Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Animal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 ANIMAL DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Animal Drugs by Major Manufacturers
11.2 Production Value of Animal Drugs by Major Manufacturers
11.3 Basic Information of Animal Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Animal Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Animal Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANIMAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis
12.1.1 Company profile
12.1.2 Representative Animal Drugs Product
12.1.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Zoetis
12.2 Boehringer Ingelheim
12.2.1 Company profile
12.2.2 Representative Animal Drugs Product
12.2.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.3 Bayer
12.3.1 Company profile
12.3.2 Representative Animal Drugs Product
12.3.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.4 Elanco Animal Health
12.4.1 Company profile
12.4.2 Representative Animal Drugs Product
12.4.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
12.5 Ceva
12.5.1 Company profile
12.5.2 Representative Animal Drugs Product
12.5.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Ceva
12.6 Dechra
12.6.1 Company profile
12.6.2 Representative Animal Drugs Product
12.6.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Dechra
12.7 Merck
12.7.1 Company profile
12.7.2 Representative Animal Drugs Product
12.7.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Merck
12.8 Virbac
12.8.1 Company profile
12.8.2 Representative Animal Drugs Product
12.8.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Virbac
12.9 Vetoquinol
12.9.1 Company profile
12.9.2 Representative Animal Drugs Product
12.9.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL DRUGS
13.1 Industry Chain of Animal Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANIMAL DRUGS
14.1 Cost Structure Analysis of Animal Drugs
14.2 Raw Materials Cost Analysis of Animal Drugs
14.3 Labor Cost Analysis of Animal Drugs
14.4 Manufacturing Expenses Analysis of Animal Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Animal Drugs in This Report
1.2 Commercial Types of Animal Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Animal Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Animal Drugs
1.5 Market Status and Trend of Animal Drugs 2013-2023
1.5.1 Global Animal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Animal Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Animal Drugs 2013-2017
2.2 Sales Market of Animal Drugs by Regions
2.2.1 Sales Volume of Animal Drugs by Regions
2.2.2 Sales Value of Animal Drugs by Regions
2.3 Production Market of Animal Drugs by Regions
2.4 Global Market Forecast of Animal Drugs 2018-2023
2.4.1 Global Market Forecast of Animal Drugs 2018-2023
2.4.2 Market Forecast of Animal Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Animal Drugs by Types
3.2 Sales Value of Animal Drugs by Types
3.3 Market Forecast of Animal Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Animal Drugs by Downstream Industry
4.2 Global Market Forecast of Animal Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Animal Drugs Market Status by Countries
5.1.1 North America Animal Drugs Sales by Countries (2013-2017)
5.1.2 North America Animal Drugs Revenue by Countries (2013-2017)
5.1.3 United States Animal Drugs Market Status (2013-2017)
5.1.4 Canada Animal Drugs Market Status (2013-2017)
5.1.5 Mexico Animal Drugs Market Status (2013-2017)
5.2 North America Animal Drugs Market Status by Manufacturers
5.3 North America Animal Drugs Market Status by Type (2013-2017)
5.3.1 North America Animal Drugs Sales by Type (2013-2017)
5.3.2 North America Animal Drugs Revenue by Type (2013-2017)
5.4 North America Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Animal Drugs Market Status by Countries
6.1.1 Europe Animal Drugs Sales by Countries (2013-2017)
6.1.2 Europe Animal Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Animal Drugs Market Status (2013-2017)
6.1.4 UK Animal Drugs Market Status (2013-2017)
6.1.5 France Animal Drugs Market Status (2013-2017)
6.1.6 Italy Animal Drugs Market Status (2013-2017)
6.1.7 Russia Animal Drugs Market Status (2013-2017)
6.1.8 Spain Animal Drugs Market Status (2013-2017)
6.1.9 Benelux Animal Drugs Market Status (2013-2017)
6.2 Europe Animal Drugs Market Status by Manufacturers
6.3 Europe Animal Drugs Market Status by Type (2013-2017)
6.3.1 Europe Animal Drugs Sales by Type (2013-2017)
6.3.2 Europe Animal Drugs Revenue by Type (2013-2017)
6.4 Europe Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Animal Drugs Market Status by Countries
7.1.1 Asia Pacific Animal Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Animal Drugs Revenue by Countries (2013-2017)
7.1.3 China Animal Drugs Market Status (2013-2017)
7.1.4 Japan Animal Drugs Market Status (2013-2017)
7.1.5 India Animal Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Animal Drugs Market Status (2013-2017)
7.1.7 Australia Animal Drugs Market Status (2013-2017)
7.2 Asia Pacific Animal Drugs Market Status by Manufacturers
7.3 Asia Pacific Animal Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Animal Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Animal Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Animal Drugs Market Status by Countries
8.1.1 Latin America Animal Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Animal Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Animal Drugs Market Status (2013-2017)
8.1.4 Argentina Animal Drugs Market Status (2013-2017)
8.1.5 Colombia Animal Drugs Market Status (2013-2017)
8.2 Latin America Animal Drugs Market Status by Manufacturers
8.3 Latin America Animal Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Animal Drugs Sales by Type (2013-2017)
8.3.2 Latin America Animal Drugs Revenue by Type (2013-2017)
8.4 Latin America Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Animal Drugs Market Status by Countries
9.1.1 Middle East and Africa Animal Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Animal Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Animal Drugs Market Status (2013-2017)
9.1.4 Africa Animal Drugs Market Status (2013-2017)
9.2 Middle East and Africa Animal Drugs Market Status by Manufacturers
9.3 Middle East and Africa Animal Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Animal Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Animal Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Animal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Animal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 ANIMAL DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Animal Drugs by Major Manufacturers
11.2 Production Value of Animal Drugs by Major Manufacturers
11.3 Basic Information of Animal Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Animal Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Animal Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ANIMAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Zoetis
12.1.1 Company profile
12.1.2 Representative Animal Drugs Product
12.1.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Zoetis
12.2 Boehringer Ingelheim
12.2.1 Company profile
12.2.2 Representative Animal Drugs Product
12.2.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.3 Bayer
12.3.1 Company profile
12.3.2 Representative Animal Drugs Product
12.3.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.4 Elanco Animal Health
12.4.1 Company profile
12.4.2 Representative Animal Drugs Product
12.4.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
12.5 Ceva
12.5.1 Company profile
12.5.2 Representative Animal Drugs Product
12.5.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Ceva
12.6 Dechra
12.6.1 Company profile
12.6.2 Representative Animal Drugs Product
12.6.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Dechra
12.7 Merck
12.7.1 Company profile
12.7.2 Representative Animal Drugs Product
12.7.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Merck
12.8 Virbac
12.8.1 Company profile
12.8.2 Representative Animal Drugs Product
12.8.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Virbac
12.9 Vetoquinol
12.9.1 Company profile
12.9.2 Representative Animal Drugs Product
12.9.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL DRUGS
13.1 Industry Chain of Animal Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ANIMAL DRUGS
14.1 Cost Structure Analysis of Animal Drugs
14.2 Raw Materials Cost Analysis of Animal Drugs
14.3 Labor Cost Analysis of Animal Drugs
14.4 Manufacturing Expenses Analysis of Animal Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
